Drug details

Jadenu (deferasirox tablets)

type of Chelators

Jadenu (deferasirox) is an iron chelator used to treat chronic iron overload due to blood transfusions in patients 2 years of age and older, and chronic iron overload in non-transfusion-dependent thalassemia syndromes (NTDT) in patients 10 years of age and older.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• nausea,
• upper stomach pain,
• loss of appetite,
• itching,
• dark urine,
• fever,
• easy bruising,
• unusual bleeding,
• pale skin,
• lightheadedness,
• shortness of breath,
• cold hands and feet,
• chills,
• tiredness,
• clay-colored stools,
• yellowing of the skin or eyes (jaundice),
• sore throat,
• skin pain,
• little or no urination,
• mouth sores,
• swelling in your feet or ankles,
• bloody or tarry stools,
• skin sores,
• burning in your eyes,
• red or purple skin rash that spreads and causes blistering and peeling,
• coughing up blood, and
• vomit that looks like coffee grounds
• problems with vision or hearing,

The following drugs are related to Jadenu, either as a replacement or used together:

• Exjade (deferasirox)
• Ferriprox (deferiprone)
• Desferal (deferoxamine)
• Reblozyl (luspatercept-aamt for injection)